Dawen Sui

2.7k citations
46 papers · 1.6k indexed · h-index 22
Topics
Cancer Immunotherapy and Biomarkers (9 papers)Cutaneous lymphoproliferative disorders research (6 papers)Immunotherapy and Immune Responses (5 papers)
Partner nations
United StatesChinaCanada

In The Last Decade

Dawen Sui

45 papers receiving 1.5k citations

Peers

Dawen Sui
Comparison fields: 5 of 112
  • Oncology 588
  • Psychiatry and Mental health 296
  • Dermatology 284
  • Pathology and Forensic Medicine 260
  • Epidemiology 222
Replace Christos Christodoulou with:
Christos Christodoulou Greece
Stacie Hudgens United States
Samario Chaitchik Israel
Andrea Eberle Germany
Shigeru Imoto Japan
Cor van den Bos Netherlands
Anna Lee United States
Koen De Geest United States
K-M Myhr Norway
Parvin Ganjei‐Azar United States
Dawen Sui relative to Christos Christodoulou Greece Christos Christodoulou's profile →
Citations per field
00.5×1.5×2.3×
Christos Christodoulou · 1×
Citations per year

Countries citing papers authored by Dawen Sui

Since Specialization
Citations

This map shows the geographic impact of Dawen Sui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawen Sui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawen Sui more than expected).

Fields of papers citing papers by Dawen Sui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawen Sui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawen Sui. The network helps show where Dawen Sui may publish in the future.

Co-authorship network of co-authors of Dawen Sui

This figure shows the co-authorship network connecting the top 25 collaborators of Dawen Sui. A scholar is included among the top collaborators of Dawen Sui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawen Sui. Dawen Sui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 2
4 16
5 25
6 6
7 25
8 29
9 29
10 38
11 5
12 4
13 16
14 25
15 14
16 164
17 84
18 32
19 66
20 91

About Dawen Sui

Dawen Sui is a scholar working on Dermatology, Oncology and Immunology, having authored 46 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Cutaneous lymphoproliferative disorders research (6 papers) and Immunotherapy and Immune Responses (5 papers). The work is most often cited by research in Dermatology (284 citations), Oncology (588 citations) and Psychiatry and Mental health (296 citations). Dawen Sui has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Leslie R. Schover, Leah Neese, Andrea L. Canada, Madeleine Duvic, Rakhshandra Talpur, Pamela Gangar, Rosell Jenkins, Michael T. Tetzlaff, Audra L. Clos and Janice Ritch. Their work appears in journals such as Journal of Clinical Oncology, Blood and Advanced Functional Materials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026